LICAVIR Study Synopsis and Table Shells

Study identification

• EU PAS number:
  EUPAS44830
• Study ID:
  44831
• Official title and acronym:
  LICAVIR Study Synopsis and Table Shells
• DARWIN EU® study:
  No
• Study countries:
  France
• Study description:
  A retrospective data collection from a cohort of patients with chronic HCV infection, who developed HCC up to the end of 2019.
• Study status:
  Finalised

Study timelines

Date when funding contract was signed

Planned: 19/07/2021

Actual: 19/07/2021

Study start date

Planned: 19/07/2021

Actual: 19/07/2021

Date of final study report

Planned: 24/09/2021

Actual: 24/09/2021

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

AbbVie

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable

Other study registration identification numbers and links

P21-900